It has recently been shown, using either genetically engineered mutant mice (nitric oxide synthase [NOS] knock out) or specific pharmacological tools, that type I NOS (neu ronal isoform of NOS, [nNOS]) participates in coupling cere bral blood flow to functional activation, However, it has not been clearly established whether the associated metabolic re sponse was preserved under nNOS inhibition and whether this action was exerted homogeneously within the brain, To address these issues, we analyzed the combined circulatory and meta bolic consequences of inhibiting the nNOS both at rest and during functional qctivation in the rat anesthetized with (X chloralose, Cerebral blood flow and cerebral glucose use (CGU) were measured autoradiographically using [14C]iodo antipyrine and e4C]2-deoxyglucose during trigeminal activa tion induced by unilateral whiskers stimulation in vehicle-and
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In rodents, activation of the whisker-to-barrel pathway has long been used as an experimental model to study such relationships, because in this species, there exists a one-to-one relationship between the organization of the 7 -nitroindazole-treated rats, Our data show that inhibition of nNOS globally decreased CBF without altering CGU, indicat ing that NO-releasing neurons play a significant role in main taining a resting cerebrovascular tone in the whole brain, Dur ing whisker stimulation, nNOS inhibition totally abolished the cerebrovascular response only in the second order relay stations (thalamus and somatosensory cortex) of the trigeminal relay without altering the metabolic response, These findings provide evidence that the involvement of neurally-derived NO in cou pling flow to somatosensory activation is region-dependent, and that under nNOS inhibition, CBF and CGU may vary in dependently during neuronal activation, Key Words: Autora diography-Trigeminal pathway-7-Nitroindazole-Cerebral blood flow-Cerebral glucose use, whiskers and specific units within the primary somato sensory cortex. Input from these peripheral sensory or gans projects to the contralateral cortex via two major relay stations: the ipsilateral trigeminal nuclei and the contralateral ventral posteromedial thalamic nucleus. In the cortex, cell bodies in layer IV are arranged in ana tomically distinct units called "barrels", each barrel be ing supplied by one penetrating artery (Woolsey and Van der Loos, 1970; Cox et aI., 1993;  for review, Waite and Tracey, 1995) . There are two important advantages of this model for investigations related to the coupling of blood flow, metabolism, and neuronal function: first, the physiological mode of activation and second, the large somatotopic representation of the posteromedial barrel subfield (20% of the primary somatosensory cortex in the rat) (Welker, 1971) . Therefore, as previously men tioned by others (Greenberg et aI., 1979; Ginsberg et aI., 1987) , this whisker-to-barrel system is ideally suited for the study of local flow/metabolism relationships.
Despite the large number of studies devoted to the characterization of the mechanisms underlying the cou pling of cerebral blood flow to brain function, the me-diators involved in this physiological coupling have yet to be fully elucidated (Iadecola, 1993 for references). The possible role of nitric oxide (NO) in the vasodilatory response elicited by vibrissal stimulation has been inves tigated by several authors using nonspecific inhibitors of the different isoforms of the NO synthase (NOS) (Dir nagl et aI., 1993; Dirnagl et aI., 1994; Wang et aI., 1993a; Irikura et aI., 1994; Adachi et aI., 1994) . The effect of inhibiting NOS on the hyperemia induced by stimulation of the trigemi . nal pathway in the rat was not conclusive. More recent studies using genetically engineered mutant mice lacking either the type I (neuronal) NOS gene or the type III (endothelial) NOS gene have provided more con vincing evidence for an important role of neurally de rived NO in the coupling of blood flow to brain function (Ma et aI., 1996; Ayata et aI., 1996) .
The assumption that neuronal NOS (nNOS) mediates the vascular response to somatosensory stimulation in the somatosensory cortex is supported by our recent au toradiographic study in which we used 7-nitroindazole (7-NI) as a selective inhibitor of nNOS (Cholet et aI., 1996) . However, 7-NI did not modify the vascular re sponse at the site of termination of primary afferents (trigeminal nuclei). This result underlines the fact that the role of nNOS in mediating the cerebrovascular re sponse to a functional activation is not homogeneous < within the central nervous system.
The mechanisms by which inhibition of nNOS attenu ates the cerebrovascular response have not yet been elu cidated. In particular, it has not been clearly established whether the metabolic response was preserved after ad ministration of NOS inhibitors.
Therefore, in the current study, we used the quantita tive autoradiographic technique with [ 14 C]iodoantipyrine and [ 14 C]2-deoxyglucose as tracers, to measure local ce rebral blood flow and cerebral glucose use (CGU) re spectively, during a functional activation induced by whisker stimulation. The consequences of inhibiting nNOS with 7-NI were analyzed on resting CBF and CGU (in selected nonactivated brain regions) and on CBF and CGU changes in all activated regions of the trigeminal pathway.
MATERIALS AND METHODS

Animals
The experimental protocols were approved by the Bureau de la Protection Animale of the Ministere de I' Agriculture (autho rization Number 02935 for 1.S. and 03001 for P.L.).
The experiments were performed on 48 adult male Sprague Dawley (OFA) rats weighing 265 to 370 g provided from IFFA CREDO (France). The rats were housed in groups of 4, they were given food (Pietrement granule 'MS20' entretien et el evage) and water ad libitum, in an ambient temperature of 22 ± 2°C (40% to 60% humidity) and a 12-hour lightlI 2-hour dark ness cycle.
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Experimental procedure
The same anesthetic and surgical protocols were followed for the four experimental protocols used for CBF measurement (protocols I and 2), CGU measurement (protocol 3) and for NOS activity assay (protocol 4).
Anesthesia was induced with 3.5% halothane administered through a vaporizer (Halothane Vapor 19.3, Drager, Germany), periodically calibrated using an Anesthetic Agent Monitor (7860, Kontron Instruments, England) in a gas mixture of 30% O2 -70% N2• and maintained under I % to 1.5% halothane during the whole surgical procedure (30 to 35 minutes dura tion). Alpha-chloralose (40 mg/kg) was administered subcuta neously in the axillary brown adipose tissue 5 minutes after halothane induction, for maintenance of anesthesia after sur gery. Such anesthetic regimen has been previously shown to induce a stable anesthetic state for more than 3 hours in the rat (Bonvento et aI., 1994a) . Body temperature was maintained at 37.5°C with a heating pad thermostatically controlled by a rectal probe (Homeothermic Blanket Control Unit, Harvard App., South Natick, MA, U.S.A.). Both femoral veins were cannulated for drug administration and replacement fluids.
Cannulae were also placed in the femoral arteries to allow measurement of blood gas tensions and continuous monitoring of arterial blood pressure (Gould RS 3400, Gould Electronics, Cleveland, OH, U.S.A.). Lidocai'ne gel (2%) was applied to the surgical wounds before closure and a tracheotomy was per formed. Thereafter, the rats were placed in a stereotaxic frame Once a suitable placement was obtained, the probe was left at that site for the duration of the experiment. About 2 hours after the induction of anesthesia (i.e., I hour and 30 minutes after halothane removal), the rats received either 7-NI, (25 mg/kg, intraperitoneally, Research Biochemicals International) dis solved in arachis oil (n = 5) or equivalent volume of vehicle (n = 5), and CBF was recorded during 30 minutes, corresponding to the maximal effect of 7-NI (Moore et aI., 1993b) . The laser Doppler flow, volume, and velocity signals were monitored on-line via an analog-to-digital convertor (Lab PC, National instrument) in a microcomputer. All data were collected and stored on disk for later analysis.
Protocol 2. Cerebral blood flow measurement using iodo antipyrine autoradiography. As previously described (Cholet et aI., 1996) , cerebral blood flow was quantitatively measured using the r 14C]iodoantipyrine autoradiographic technique (Sakurada et aI., 1978) which allows measurement of CBF in all relays of the trigeminal pathway. 7-Nitroindazole (n = 6) or vehicle (n = 6) was injected 2 hours after induction of anes thesia, as in protocol I. Twenty five minutes later, the right whiskers of the row C were stimulated at 4 Hz using a home made electromagnetic device to which was attached a 10-cm long steel tube. The radioactive tracer (12.S /-LCi/100 g body weight) was infused intravenously S minutes after, over 30 seconds by a pump programmed to produce a linear arterial input function of tracer concentration. Ten arterial samples were collected over the infusion period. The rats were killed using a bolus of sodium pentobarbital. The time of circulatory arrest used for CBF calculation was carefully determined using the arterial pressure recording. After centrifugation, twel ve 20-fLL samples of plasma were mixed with 0.5 mL of a tissue solubilizer (Solulyte, Baker and propanol-2, 4V, I V). Then, they were filled with S mL of scintillation cocktail (Lipotluor, Baker) and their radioactivity was counted (Tricarb 1600 TR Packard).
Protocol 3. Cerebral glucose use measurement using 2-Deoxyglucose autoradiography. Cerebral glucose utilization was quantitatively measured using the [ 14Cj2-deoxyglucose au toradiographic technique (Sokoloff et aI., 1977b) . To avoid blood glucose concentration variations during the CGU mea surement, the rats were fasted overnight before the experimen tal procedure. One hour and fifty minutes after the induction of anesthesia, rats received either 7-NI (n = 8) or vehicle (n = 8) as in protocol 1. Twenty minutes later, mechanical stimulation (4 Hz) of the right C whiskers was started. The l 14Cj2deoxyglucose (0.8 mL saline solution containing II fLCil lOO g body weight) was infused intravenously S minutes after, and the stimulatiofi was continued for 4S minutes. Twenty arterial samples were collected throughout the 4S minutes and were immediately centrifuged and kept cooled. The glycemia and the e4CJ radioactivity were determined respectively on 10-and 20-fLL samples of plasma. The slopes were compared using a Student's t-test (Zar, 1984) .
Second, a repeated-measures analysis of variance was per formed on the log transform of the data sets as previously described by McCulloch et a!. (1982) .
RESULTS
Systemic effects of 7-nitroindazole
Intraperitonally administered 7-NI (25 mg/kg) did not significantly change either of the physiological variables measured, rectal temperature, arterial blood gas tensions and pH, glycemia, and hematocrit level (Table 1) as we previously observed (Cholet et aI., 1996) . Figure 1 also shows that 7-NI had no effect on MABP nor heart rate throughout the 30 minute-experiment, compared with ve hicle-injected rats (Fig. 1, Table 1 ).
Effect of 7-nitroindazole on resting local cerebral blood flow and cerebral glucose use Figure 1 represents the time-course of the cortical blood flow changes measured by laser-Doppler flowme try after treatment with 7-NI. Blood flow decreased pro gressively and significantly with maximal effect reached at 30 minutes (-22%) compared with vehicle-treated rats.
When measured using the autoradiographic technique, Values are expressed as mean ± SO (n = 8 in each group). No significant difference was noted in any parameter in the two groups (Student's unpaired t test). No significant change in the glycemia was noted in the course of the cerebral glucose use measurement (Student's paired t test). 7-NI, 7-nitroindazole.
CBF significantly decreased in most of the brain struc tures examined (from -12 to -3S%) 30 minutes after 7-NI injection (Tables 2, 3 ). In contrast, no significant effect of 7-NI on the CGU was noted either in the non activated sides of the relays of the trigeminal pathway (Table 4 ) or in the 13 regions examined outside of the trigeminal pathway (Table S) .
Because 7-NI decreased CBF without affecting CGU, there was a resetting of the flow-metabolism relationship in 7-NI-treated rats (Fig. 2 ). Significant correlation be tween CGU and CBF in control group (r = 0.79) was maintained in treated group (r = 0.67), but the slope of the correlation line was significantly decreased under 7-NI (1.8 versus 1.0, P < O.OS). Repeated-measures analysis of variance confirmed that the resetting of the flow-metabolism relationship was significant (P < O.OS). In control conditions, unilateral C whisker stimulation resulted in distinct CBF increases from 2S% to 28% in the ipsilateral trigeminal nuclei and of 6 and 29% in the contralateral VPM and the contralateral FrPaSS cortex, respectively (Table 2) . Whisker stimulation induced cor responding localized CGU increases from 42% to 70% in the ipsilateral trigeminal nuclei (SpSc, SpSi, SpSo, and PrS) and of 39% and 66% in the contralateral VPM and FrPaSS cortex, respectively (Table 4, Fig. 3) . Cerebral blood flow increases under 7-NI were similar to those in control rats in the ipsilateral trigeminal nuclei (from 22% to 29%) but no significant vasodilation was noted in the contralateral VPM and FrPaSS cortex (Table 2, Fig. 3 ). Compared with control animals, similar increases of CGU were observed in 7-NI-treated animals during stimulation with increases from 47% to 71 % in the ipsi lateral first-order relay stations (SpSc, SpSi, SpSo, and PrS) and of 30% and 7S% in the contralateral second-J Cereb Blood Flow Metab, Vol. 17, No. II, 1997 order relay stations (V PM and FrPaSS cortex) (Table 4 and Fig. 3 ).
Effect of 7-nitroindazole on nitric oxide synthase activity
In vehicle treated-rats, NOS activity was 31.7 ± IS.4, S.4 ± 2.6, and 2.8 ± 0.9 pmol activity·mg tissue-1 'min-1 in the cerebellum, pons-medulla, and somatosensory cor tex, respectively. Administration of 7-NI significantly reduced NOS activity by 74%, 89%, and 79% in the same structures, respectively (Fig 4) . (1996) .
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DISCUSSION
This autoradiographic study analyzed the combined circulatory and metabolic consequences of inhibiting the nNOS during a functional activation in the ex-chloralose anesthetized rat. We have provided evidence that (1) NO-releasing neurons play a significant role in maintain ing a resting cerebrovascular tone in the whole brain; (2) in the somatosensory cortex, inhibition of nNOS abol ishes the vascular response to whisker stimulation with- Values are expressed as mean ± SD (n = 6 in each group). i, ipsilateral; c, contralateral to the stimulus. * P < 0.05, t P < 0.01: significantly different from the nonactivated side (Student's paired I-test). §P < 0.05; lip < 0.01; 'liP < 0.001 significant differences in the 7-NI group compared with the control group for a given side (Student's unpaired I-test). Values are expressed as mean ± SD (n 8 in each group). i, ipsilateral; c, contralateral to the stimulus. * p < 0.001, activated side significantly different from respective non-activated side (Student's paired t-test). There were no significant differences between 7-NI and the control group for a given side (Student's unpaired t-test). CGU, cerebral glucose use; 7-NI, 7-nitroindazole. out affecting the metabolic activation; and (3) nNOS does not mediate the vascular and metabolic response to somatosensory activation in the first-order relay stations of the trigeminal pathway. These observations suggest that the involvement of neurally derived NO in coupling t10w to somatosensory activation is region dependent and that CBF and CGU may vary independently under nNOS inhibition. Values are expressed as mean ± SD (n = 8 in each group). i, ipsilateral; c, contralateral to the stimulus. No significant difference was noted between the ipsilateral and the contralateral sides of each region in either group (Student's paired I-test). No significant difference was noted between the 7-NI and the control group for each structure (Student's unpaired t-test). CGU, cerebral glucose utilization; 7-NI, 7-nitroindazole. (0) and 7-NI-treated (e) animals. Each point represents mean CGU and mean CBF values (expressed in natural logarithms) obtained for one brain structure (nonstimu lated sides of the trigeminal pathway and averaged values for the 13 other brain regions). Repeated-measures analysis of variance indicated that the resetting of the flow-metabolism relationship was significant (P < 0.05).
Differentiated effect of 7-nitroindazole on resting cerebral glucose use and cerebral blood flow
A number of recent studies have highlighted the criti cal importance of the dose, the route of administration, and the time elapsed after injection of a potential nNOS inhibitor to achieve an efficient blockade of the enzyme responsible for inf vivo NO production (Yoshida et aI., 1994; Mackenzie et aI., 1994; Moore et aI., 1993a) .
In the present study, 7-NI was administered intraperi tonally at 25 mg/kg and CBF and CGU were measured 30 minutes thereafter. Using these parameters, we indeed obtained a marked inhibition of nNOS (74% to 89%). We can thus reasonably assume that our data represent the optimal effect of 7-NI on cerebrovascular reactivity as also evidenced by our laser-Doppler flowmetry re sults. With regard to the specificity of 7-NI versus the neuronal form of NOS, we observed that the administra tion of 7-NI was devoid of any marked cardiovascular effects. This is consistent with previous studies using 7-NI (from 10 to 100 mg/kg) in several species either anesthetized or conscious (Yoshida et aI., 1994; Macken zie et aI., 1994; Moore et aI., 1993a; Kovach et ai, 1994; Wang et aI., 1995; Zhang et aI., 1995; ladecola et a!., 1996a) . Also, the lack of influence of 7-NI on the vaso relaxant action of acetylcholine (Yoshida et a!., 1994; Zhang et aI., 1995; Iadecola et aI., 1996a ) confirms that 7-NI is a selective inhibitor of neuronal NOS activity.
Alpha-chloralose is a suitable anesthetic for the study of cerebrovascular and metabolic responses to neuronal activation in experimental conditions that preclude the use of conscious animals (Bonvento et aI., 1994a) . It produces only minor and relatively homogeneous changes in CBF (Bonvento et a!., 1994a; Bonvento et aI., 1989; Lacombe et a!., 1992) and glucose use (Dudley et a!., 1982) . Alpha-chloralose maintains the coupling be tween neuronal function and metabolism (Ueki et aI., 1988 (Ueki et aI., , 1992 . This is a unique feature because such cou pling is not maintained under halothane, pentobarbital, and nitrous oxide anesthesia (Ueki et aI., 1992) . We also provided evidence that the magnitudes of the CGU re sponses to somatosensory stimulation (+39 to 70%) are of the same order as that reported in conscious rats (Di etrich et aI., 1986) . Alpha-chloralose at doses of up to 80 mg/kg has been shown to maintain the coupling between neuronal function and CBF (Ueki et aI., 1988; Lindauer et aI., 1993) . Finally, the similarity of the slopes calcu lated from the linear regression of the CBF/CGU values in conscious (m = 2.0, Kelly et aI., 1995) and chlora lose-anesthetized rats (m = 1.8, present result) suggests that this anesthetic maintains a physiological CBF/CGU relationship.
Using laser-Doppler flowmetry and autoradiography, we have found that 7-NI decreases basal CBF, an obser vation supported by several other reports including ours, in which specific or nonspecific neuronal NOS inhibitors were used in conscious or anesthetized animals (Bon vento et aI., 1994b; Montecot et a!., 1997; Iadecola et aI., 1994a) . However, we have observed that 7-NI does not modify resting CGU in any brain regions examined as reported by Kelly et al. in conscious rats (1995) . Con sistently, other nonspecific inhibitors of NO synthase did not alter resting CGU either (Wang et aI., 1993; Iadecola and Xu, 1994b; Takahashi et aI., 1995) . In agreement with this is the lack of influence of NOS inhibition on global cerebral oxygen consumption (Wang et aI., 1993; ladecola et aI., 1994a) . This is surprising in view of the well recognized role of NO as a major neuronal messen ger involved in many physiological regulations including cerebrovascular reactivity (Takahashi et aI., 1995; Iadecola et aI., 1994a) . These results collectively support the idea that 7-NI induces a global and appreciable de crease of resting CBF without altering brain metabolism.
The resetting of the flow-metabolism relationship ob served after 7-NI treatment indicates that neurally derived NO directly participate in the maintenance of a resting cerebrovascular tone, as observed by Kelly et al. (1995) . We previously reported that with the use of 7-NI, the cerebrovascular reactivity elicited by whisker stimula tion was abolished in the contralateral second-order relay stations, the VPM, and the FrPaSS cortex, but was pre served in the ipsilateral trigeminal nuclei (Cholet et aI., 1996) . This result contrasts with the previously reported unchanged percentage increases in CBF after the admin istration of L-NAME (a nonspecific NOS inhibitor) in conscious rats (Adachi et aI., 1994) . The explanation for such a discrepancy is unclear, but it seems unlikely that (A) and under 7-NI (8). The coronal sections of the rat brain include: Sp5i (AB), FrPaSS cortex (CD) and VPM (CD). Color scales provide quantitative interpretation of CBF expressed in mL 100 g-1 min-1 and CGU expressed in �mol 100 g-1 min-1. Note that despite the vascular reactivity to whiskers stimulation is abolished in VPM and FrPaSS cortex after 7-NI injection, the metabolic response is preserved. In contrast, 7-NI does not modify the vascular and metabolic responses in Sp5i.
1 00 anesthesia is responsible for the differentiated cerebro vascular effects of NOS inhibition. Indeed, the involve ment of NOS in either the maintenance of a resting ce rebrovascular tone (see above) or in the cerebrovascular response to hY Ji1 ercapnia was shown to be identical in conscious (Bonvento et aI., 1994b) and anesthetized ani mals (Iadecola et aI., 1994) . We now provide evidence that this differential circu latory influence of nNOS inhibition is not a consequence of a differential metabolic effect because 7-NI did not modify the metabolic response to whisker stimulation in any of the six trigeminal relays studied. In agreement with this result, is the fact that NOS inhibition does not affect somatosensory-evoked potentials elicited by vi brissae activation in the chloralose anesthetized rat (Lindauer et aI., 1996) . Consequently, the close relation ship that exists between CBF and CGU which is main tained during whisker stimulation in control rats, is dis rupted in the second-order relay stations of the trigeminal pathway (VPM and FrPaSS cortex) after inhibition of the neuronal NO synthase activity, while it is preserved in the trigeminal nuclei. This indicates that the involvement of nNOS in the coupling of flow to functional activation is region dependent and is mainly effective in the cere bral cortex. It is noteworthy that nNOS has also been shown to mediate the vasodilation from cerebellar par allel fibers stimulation (Iadecola et aI., 1996) suggesting that not only the cortical NO neurons participate in such coupling. Our results also suggest that in other brain structures, other mediators must be required to couple neuronal function to vasodilation, even within the same activated pathway.
The main finding of the current study is that with the use of 7-NI, the local cortical metabolic response is com-pletely preserved despite an abolished flow response. This observation challenges the seminal but still prevail ing hypothesis of Roy and Sherrington (1890) , that the microvascular adjustments in response to changes in neuronal activity are designed to match the metabolic needs. Therefore, our results indicate that either these two variables are not inevitably linked, or that the CBF changes can serve purposes other than adjusting energy supply to increased neuronal metabolic demands. This latter hypothesis has long been known as 'luxury perfu sion' (Lassen, 1966) . This term implies that blood flow increases in large excess in face of the limited needs in supplementary substrates (glucose and oxygen) during a functional activation. According to Ueki et aI. (1988) , the brain has the capacity to increase its fractional arterial extraction of glucose and oxygen to some extent without requiring an increased blood supply. Such a hypothesis was recently substantiated by a study that shows a con stant CBF response to a physiological brain activation in humans with progressive arterial hypoglycemia leading to a progressive reduction in glucose delivery to the ac tivated area (Powers et aI., 1996) .
What are the putative sources of glucose in such con ditions that preclude any blood flow changes? One hy pothesis would be that glucose transport through endo thelial cells can be modulated during functional activa tion. Indeed Farrel et aI. (1991) observed that 40% of the GLUTl isoform (55 kd), the specific endothelial glucose transporter, are located within the cytoplasmic compart ment. The possible translocation of GLUTl from the cytoplasm to the plasma membrane may provide one mechanism for rapid up-regulation of the endothelial glucose transporter activity. Another hypothesis is that glucose is derived from another source such as glycogen in astrocytes (Magistretti et aI., 1993) .
In the current report, we did not investigate the neu ronal mechanisms of the metabolic and flow responses induced by somatosensory stimulation. However, re cently accumulated evidence strongly supports the im plication of glutamate release as a major step of the signaling process coupling neuronal activity to metabo lism and CBF. This is of major interest because gluta mate can be considered as one of the major neurotrans mitters involved in the processing of somatosensory in formation (Zilles and Wree, 1995; Salt, 1986; Klockgether, 1987) .
Indeed, it has been shown that glutamate exerts a metabolic function in astrocytes, by activating glycolysis and inducing the lactate synthesis, providing the acti vated neurons with energy-producing substrates (Pellerin and Magistretti, 1994) .
Considering the vascular event, recent evidence sug gests that activation of glutamate receptors participates in the mechanisms of functional hyperemia during cer ebellar parallel fibers activation induced increased syn-aptic actlVlty (Akgoren, 1994; Iadecola et aI., 1996b) . One hypothesis of the mechanism by which such gluta mate receptor activation leads to flow increase relies on an enhanced NO production via an increased Ca++ entry (Faraci and Brian, 1994) . In view of all these observa tions, glutamate could be a suitable signal to increase both CGU and CBF during a functional activation via either its glycolysis-induced uptake of glucose in astro cytes and the stimulation of NOS activity.
In conc1usiQn, our results provide evidence for a major and direct involvement of nNOS in the cortical flow coupling to somatosensory stimulation. In addition, the striking flow/metabolism uncoupling observed at the cortical level suggests that the vascular and metabolic responses, despite the fact that they probably share a common triggering signal (e.g., glutamate) are most likely controlled by distinct signaling processes.
